Ginkgo Bioworks has been busy, announcing not just one but three acquisitions and the creation of a network backed by 25 partners that will offer ‘end-to-end’ services to R&D clients.

Ginkgo Bioworks Holdings, Inc. (DNA) ended the recent trading session at $8.27, demonstrating a +1.35% swing from the preceding day's closing price. The stock outpaced the S&P 500's daily gain of 0.27 ...

Every investor in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 48% to be ...

BOSTON, Nov. 5, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it ...

Ginkgo Bioworks Holdings Inc, based in Boston, Massachusetts, specializes in cell programming to revolutionize the production of various products. By manipulating cells, they create novel ...

In this article, we are going to take a look at where Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) stands against other most promising gene editing stocks to buy according to hedge funds. The ...

Ginkgo Bioworks had a negative net margin of 486.98% and a negative return on equity of 63.09%. On average, sell-side analysts expect that Ginkgo Bioworks Holdings, Inc. will post -12.6 earnings ...

BOSTON, Nov. 5, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Every investor in Ginkgo Bioworks Holdings, Inc. ( NYSE:DNA) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 48% to be ...